Following a recent Justice Department case involving kickbacks that resulted in a $6 million settlement, the Corporate Whistleblower Center is calling on physicians to contact them about schemes involving blood testing labs that are paying doctors to order unnecessary tests.
Virginia Commonwealth University Health System (VCU Health) is hosting a series of Facebook Live interviews throughout the summer in an attempt to highlight the dangers and realities of opioid use in the U.S.
Texas Medical Center (TMC) recently reported on the efforts of McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth) microbiologists to develop a new treatment for patients suffering from a fungal yeast infection in the mouth known as thrush.
Penn Medicine News reported on a recent study by University of Pennsylvania researchers published in the Journal of Neuroscience that found that commercial brain training programs do not improve decision making or cognitive function.
The ability to detect skin cancer, the leading type of cancer, early could save lives, and the American Cancer Society recently shared information on how to spot skin cancer in the beginning stages when it is easily treatable and has not advanced.
Chemotherapy may save lives, but it can also cause patient hair loss – which is why pharmaceutical device maker Dignitana Inc. developed a special cap, recently FDA approved, to prevent this unpleasant side effect.
Once skin cancer in advanced stages has been surgically removed, Opdivo may be the best option to keep the malignancy at bay, according to a Phase 3 clinical trial sponsored by manufacturer Bristol-Myers-Squibb.
University of Illinois Hospital & Health Sciences System (UI Health) said it recently was named "Most Wired" health care organization for 2017 by Hospitals & Health Networks for using technology to improve operations.
Amgen said its recent studies found that patients who were given a prescription for a PCSK9 inhibitor to lower cholesterol levels had their insurance claims for the drugs initially turned down by payers.
A study by the University of Pennsylvania shows that health insurance plans with limited networks do not include places that belong to the National Comprehensive Cancer Network and other cancer centers that are among the best in the country.